Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+1.58% - - 52.02M
-1.86%-2.09%+0.11%+5.40% 50.35B
-0.29%-2.81%+387.81%+591.82% 39.21B
-0.49%+1.48%+31.16%-6.46% 34.52B
+1.53%+3.11%+15.41%+58.54% 34.6B
+1.68%-0.62%+3.30%+27.34% 27.05B
+1.13%-3.11% - - 16.68B
-1.29%-0.52%+69.24%+117.60% 15.11B
-0.66%+0.06%+13.86%+17.19% 13.85B
+2.45%+3.99%+18.20%-30.12% 13.18B
Average +0.24%+0.94%+67.38%+97.66% 27.17B
Weighted average by Cap. -0.00%+0.83%+80.69%+121.29%
Logo Genkyotex SA.
GenKyoTex SA is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.
Employees
9
  1. Stock Market
  2. Stocks
  3. GKTX Stock